Treatment of borderline resectable (BR) and locally advanced (LA) pancreatic cancer in the era of FOLFIRINOX and gemcitabine plus nab-paclitaxel: A multi-institutional study.

Authors

null

Kamran Idrees

Division of Surgical Oncology, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN

Kamran Idrees , Alexander A. Parikh , Lauren McLendon Postlewait , Sharon M. Weber , Clifford Suhyun Cho , Ahmed I. Salem , Robert C. G. Martin II, Charles Raben Scoggins , Hong Jin Kim , Jacquelyn Carr , Heather Stuart , Brent Xia , Syed Ahmed , Daniel Erik Abbott , Shishir Kumar Maithel , David A. Kooby , Nipun B. Merchant

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 451)

DOI

10.1200/jco.2016.34.4_suppl.451

Abstract #

451

Poster Bd #

N1

Abstract Disclosures

Similar Posters

First Author: Vanessa Rosas Camargo

Poster

2018 Gastrointestinal Cancers Symposium

Resection of pancreatic cancer following induction chemotherapy.

Resection of pancreatic cancer following induction chemotherapy.

First Author: Walid Labib Shaib

First Author: Hannah Marie Cherniawsky